Pure Global AI
ANVISA registration 10339840513Valid until Sep 02, 2029

HERPES VIRUS (HHV 2)

ANVISA Registration Number: 10339840513DIASORIN LTDADIASORIN MOLECULAR LLCRisk Class III
Verified
Device names
Technical name
HERPES VIRUS (HHV 2)
View exact technical-name matches →
PT: HERPES VÍRUS (HHV 2)
Commercial name
Simplexa™ HSV 1 & 2 Direct
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10339840513
Process Number
25351810151201857
CNPJ
01896764000170
Company information
Registration Holder
DIASORIN LTDA
Manufacturer
DIASORIN MOLECULAR LLC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Sep 02, 2019
Validity
02/09/2029
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840513 and manufactured by DIASORIN MOLECULAR LLC. The registration is held by DIASORIN LTDA with validity until Sep 02, 2029.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.